Faxitron awarded exclusive distribution rights for Breast Lesion Localization System The LOCalizer AMSTERDAM, Jan. 26, 2017 /PRNewswire/ — Faxitron® Bioptics, LLC and Health Beacons, Inc. today announced that Faxitron has been awarded exclusive worldwide distribution rights for Health Beacons’ RFID (Radio Frequency Identification) breast lesion localization system, the LOCalizer™, currently pending FDA 510(k) clearance.* The LOCalizer has…
Health Beacons named Innovative Healthcare Tech of the Year Finalist by MassTLC
RFID Localization System poster presentation at the 17th ASBS Annual Meeting, April 13 – 16, 2016 Dallas, TX
San Diego, CA — May 1, 2014 — Dr. Christine Dauphine, Director of the Breast Clinic at Harbor-UCLA Medical Center, will be presenting the results of the first set of human cases using Health Beacons’ radiofrequency identification (RFID) breast tumor localization system at the American Roentgen Ray Society (ARRS) 2014 Annual Meeting on May 4th in San Diego. The ARRS is a medical radiology society dedicated to advances in imaging technology.
New Clinical Trials for Evaluation of RFID Localization System for Marking and Retrieving Breast Lesions
The goal of this investigation is to obtain clinical data to show the Health Beacons Radiofrequency Identification (RFID) Localization System is safe and performs as intended as a localization device for marking and retrieving a non-palpable surgical target from the breast.